A neuroplasticity hypothesis of chronic stress in the basolateral amygdala

Yale Journal of Biology and Medicine

Volumn 86, Issue 2, 2013, Pages 117-125

  Boyle, Lara M ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Anandamide (AEA); Basolateral amygdala (BLA); Brain derived neurotrophic factor (BDNF); Chronic stress; Fatty acid amide hydrolase (FAAH); Glutamate; N methyl D aspartate (NMDA) receptor; Neuroplasticity; Smallconductance Ca2+ activated K+ channels (SK channels)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ENDOCANNABINOID; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTROPHIC FACTOR; NORADRENALIN; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ANXIETY; ANXIETY DISORDER; ARTICLE; BASOLATERAL AMYGDALA; BRAIN REGION; CHRONIC STRESS; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS;

ANANDAMIDE (AEA); BASOLATERAL AMYGDALA (BLA); BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF); CHRONIC STRESS; FATTY ACID AMIDE HYDROLASE (FAAH); GLUTAMATE; N-METHYL-D-ASPARTATE (NMDA) RECEPTOR; NEUROPLASTICITY; SMALL-CONDUCTANCE CA2+-ACTIVATED K+ CHANNELS (SK CHANNELS);

AMYGDALA; HUMANS; LEARNING; MODELS, NEUROLOGICAL; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84879037467     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Conrad C, Magariños A, LeDoux J, McEwen B. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci. 1999;113(5):902-13.
2. Wood G, Young L, Reagan L, McEwen B. Acute and chronic restraint stress alter the incidence of social conflict in male rats. Horm Behav. 2003;43(1):205-13.
3. Schafe GE, Nader K, Blair HT, LeDoux JE. Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. Trends Neurosci. 2001;24(9):540-6.
4. Maren S. Protein synthesis in the amygdala, but not the auditory thalamus, is required for consolidation of Pavlovian fear conditioning in rats. Eur J Neurosci. 2003;18(11):3080-8.
5. Rudy JW, Huff NC, Matus-Amat P. Understanding contextual fear conditioning: insights from a two-process model. Neurosci Biobehav Rev. 2004;28(7):675-85.
6. Vyas A, Mitra R, Shankaranarayana B, Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci. 2002;22:6810-8.
7. Vyas A, Pillai A, Chattarji S. Recovery after chronic stress fails to reverse amygdaloid neuronal hypertrophy and enhanced anxietybehavior. Neuroscience. 2004;128(4):667-73.
8. Rauch SL, Shin LM, Wright CI. Neuroimaging studies of amygdala function in anxiety disorders. Ann NY Acad Sci. 2003;985:389-410.
9. Lynch JW, Kaplan GA, Shema SJ. Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. N Engl J Med. 1997;337:1889-95.
10. Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB, et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry. 2000;47(9):769-76.
11. McEwen BS. Mood disorders and allostatic load. Biol Psychiatry. 2003;54(3):200-7.
12. Lopez AD, Murray CCJL. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241-3.
13. Davidson RJ. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry. 2002;51(1):68-80.
14. Etkin A, Wager T. Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia. Am J Psychiatry. 2007;164(10):1476-88.
15. Taylor D, Meader N, Pilling S, Creed F, Goldberg D. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry. 2011;198(3):179-88.
16. Radley J, Rocher A, Miller M, Janssen W, Liston C, Hof P, et al. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb Cortex. 2006;16(3):313-20.
17. Miller DB, O'Callaghan JP. Neuroendocrine aspects of the response to stress. Metabolism. 2002;51(6 Suppl 1):5-10.
18. Herman J, Tasker J, Ziegler D, Cullinan W. Local circuit regulation of paraventricular nucleus stress integration: Glutamate-GABA connections. Pharmacol Biochem Behav. 2002;71(3):457-68.
19. Herman J, Mueller N. Role of GABA and glutamate circuitry in hypothalamo-pituitaryadrenocortical stress integration. Ann NY Acad Sci. 2004;1018:35-45.
20. Chrousos GP. A healthy body in a healthy mind-and vice versa-The damaging power of "uncontrollable" stress. J Clin Endocrinol Metab. 1998;83(6):1842-5.
21. Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuroendocrine and target tissue-related causes. Int J Obes Relat Metab Disord. 2000;24(Suppl 2):S50-5.
22. Sandi C, Merino J, Cordero M, Touyarot K, Venero C. Effects of chronic stress on contextual fear conditioning and the hippocampal expression of the neural cell adhesion molecule, its phosphorylation, and L1. Neuroscience. 2001;102(2):329-39.
23. McEwen BS. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann NY Acad Sci. 2001;933:265-77.
24. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci. 1994;14(4):2047-53.
25. Kirschbaum C, Wolf O, May M, Wippich W, Hellhammer D. Stress-and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci. 1996;58(17):1475-83.
26. Lupien S, Gaurdreau S, Tchiteya B, Maheu F, Sharma S, Nair N, et al. Stress-induced declarative memory impairment in healthy elderly subjects: a relationship to cortisol reactivity. J Clin Endocrinol Metab. 1997;82(7):2070-5.
27. Gilad GM, Gilad VH, Wyatt RJ, Tizabi Y. Region-selective stress-induced increase of glutamate uptake and release in rat forebrain. Brain Res. 1990;525(2):335-8.
28. Lowy MT, Gault L, Yamamoto BK. Rapid communication: adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem. 2006;61(5):1957-60.
29. Fontella FU, Vendite DA, Tabajara AS, Porciúncula LO, Torres ILDS, Jardim FM, et al. Repeated restraint stress alters hippocampal glutamate uptake and release in the rat. Neurochem Res. 2004;29(9):1703-9.
30. Reagan LP, Rosell DR, Wood GE, Spedding M, Muñoz C, Rothstein J, et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA. 2004;101(7):2179-84.
31. Autry AE, Grillo CA, Piroli G, Rothstein JD, McEwen BS, Reagan LP. Glucocorticoid regulation of GLT-1 glutamate transporter isoform expression in the rat hippocampus. Neuroendocrinology. 2006;83(5-6):371-9.
32. Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L, et al. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci. 2005;25(13):3270-9.
33. Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci. 2004;24(14):3471-9.
34. Mattson MP, Taylor-Hunter A, Kater SB. Neurite outgrowth in individual neurons of a neuronal population is differentially regulated by calcium and cyclic AMP. J Neurosci. 1988;8:1704-11.
35. Mattson MP. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann NY Acad Sci. 2008;1144:97-112.
36. Weisenberg RC. Microtubule formation in vitro in solutions containing low calcium concentrations. Science. 1972;177(4054):1104-5.
37. Haga T, Abe T, Kurokawa M. Polymerization and depolymerization of microtubules in vitro as studied by flow birefringence. FEBS Lett. 1974;39(3):291-5.
38. Olmsted JB, Borisy GG. Characterization of mictrotubule assembly in porcine brain extracts by viscometry. Biochemistry. 1973;12(21):4282-9.
39. Mattson MP. Calcium as sculptor and destroyer of neural circuitry. Exp Gerontol. 1992;27(1):29-49.
40. Lankford KL, Letourneau PC. Evidence that calcium may control neurite outgrowth by regulating the stability of actin filaments. J Cell Biol. 1989;109(3):1229-43.
41. Adamec RE, Burton P, Shallow T, Budgell J. Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle--effective hemisphere depends on the behavior. Physiol Behav. 1999;65(4-5):739-51.
42. Mozhui K, Karlsson RM, Kash TL, Ihne J, Norcross M, Patel S, et al. Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J Neurosci. 2010;30(15):5357-67.
43. Hardingham GE, Arnold FJL, Bading H. A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat Neurosci. 2001;4(6):565-66.
44. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science. 2001;294(5541):333-9.
45. Impey S, Obrietan K, Wong ST, Poser S, Yano S, Wayman G, et al. Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron. 1998;21(4):869-83.
46. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca2+ Influx Regulates BDNF Transcription by a CREB family transcription factor-dependent mechanism. Neuron. 1988;20(4):709-26.
47. Zafra F, Castrén E, Thoenen H, Lindholm D. Interplay between glutamate and gammaaminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci USA. 1991;88(22):10037-41.
48. Horch HW, Katz LC. BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat Neurosci. 2002;5(11):1177-84.
49. Horch HW. Local effects of BDNF on dendritic growth. Rev Neurosci. 2004;15(2):117-29.
50. Lohmann C, Wong ROL. Regulation of dendritic growth and plasticity by local and global calcium dyanmics. Cell Calcium. 2005;37(5):403-9.
51. Numakawa T, Yamagishi S, Adachi N, Matsumoto T, Yokocaku D, Yamada M, et al. Brain-derived neurotrophic factor-induced potentiation of Ca2+ oscillations in developing cortical neurons. J Biol Chem. 2002;277(8):6520-9.
52. Yagasaki Y, Numakawa T, Kumamaru E, Hayashi T, Su T, Kunugi H. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J Biol Chem. 2006;281(18):12941-9.
53. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14(23):2919-37.
54. Caldeira MV, Melo CV, Pereira DB, Carvalho RF, Carvalho AL, Duarte CB. BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci. 2007;35(2):208-19.
55. Crozier RA, Black IB, Plummier MR. Blockade of NR2B-containing NMDA receptors prevents BDNF enhancement of glutamatergic transmission in hippocampal neurons. Learn Mem. 1999;6(3):257-66.
56. Cordero M, Rodriguez J, Davies H, Peddie C, Sandi C, Stewart M. Chronic restraint stress down-regulates amygdaloid expression of polysialylated neural cell adhesion molecule. Neuroscience. 2005;133(4):903-10.
57. Brusés JL, Rutishauser U. Roles, regulation, and mechanism of polysialic acid function during neural development. Biochimie. 2001;83(7):635-43.
58. Pham K, Nacher J, Hof PR, McEwen BS. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci. 2003;17(4):879-86.
59. Vutskits L, Djebbara-Hannar Z, Zhang H, Paccaud J, Durbec P, Rougon G, et al. PSANCAM modulates BDNF-dependent survival and differention of cortical neurons. Eur J Neurosci. 2001;13(7):1391-402.
60. Lubin FD, Roth TL, Sweatt JD. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci. 2008;28(42):10576-86.
61. Roth TL, Zoladz PR, Sweatt JD, Diamond DM. Epigenetic modification of hippocampal BDNF DNA in adult rats in an animal model of post-traumatic stress disorder. J Psychiatr Res. 2011;45(7):919-26.
62. He D, Neasta J, Ron D. Epigenetic regulation of BDNF expression via the scaffolding protein RACK1. J Biol Chem. 2010;285(25);19043-50.
63. Rosenkranz JA, Venheim ER, Padival M. Chronic stress causes amygdala hyperexcitability in rodents. Biol Psychiatry. 2010;67(12):1128-36.
64. Faber ESL, Delaney AJ, Sah P. SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala. Nat Neurosci. 2005;8(5):635-41.
65. Mitra R, Ferguson D, Sapolsky RM. SK2 potassium channel overexpression in basolateral amygdala reduces anxiety, stress-induced corticosterone secretion and dendritic arborization. Mol Psychiatry. 2009;14(9):847-55.
66. Faber ES, Delaney AJ, Power JM, Sedlak PL, Crane JW, Sah P. Modulation of SK channel trafficking by beta adrenoceptors enhances excitatory synaptic transmission and plasticity in the amygdala. J Neurosci. 2008;28(43):10803-13.
67. Galvez R, Mesches MH, McGaugh JL. Norepinephrine release in the amygdala in response to footshock stimulation. Neurobiol Learn Mem. 1996;66(3):253-7.
68. Di Marzo V, Deutsch DG. Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol Dis. 1998;5(6 Pt B):386-404.
69. Vaughan CW, Christie MJ. Retrograde signaling by endocannabinoids. Handb Exp Pharmacol. 2005;(168):367-83.
70. Bisogno T, Ligresti A, Di Marzo V. The endocannabinoid signaling system: biochemical aspects. Pharmacol Biochem Behav. 2005;81(2):224-38.
71. Gorzalka BB, Hill MN, Hillard CJ. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev. 2008;32(6):1152-60.
72. Gulyas A, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, et al. Segregation of two endocannabinoid-hydrolyzing enzymes into pre-and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 2004;20(2):441-58.
73. Hill MN, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, et al. Disruption of fatty acid amide hydrolysis activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry. 2012 Jul 10. [Epub ahead of print].
74. Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, et al. Antidepressant activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry. 2007;62(10):1103-10.
75. Graybeal C, Kiselycznyk C, Holmes A. Stress-Induced deficits in cognition and emotionality: a role for glutamate. Curr Top Behav Neurosci. 2012 Jan 20. [Epub ahead of print].
76. Duman RS, Monteggia LM. A Neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59(12):1116-27.
77. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15(11):7539-47.
78. Reagan LP, Hendry RM, Reznikov LR, Piroli GG, Wood GE, McEwen BS, et al. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur J Pharmacol. 2007;565(1-3):68-75.
79. Della FP, Abelaira HM, Réus GZ, Ribeiro KF, Antunes AR, Scaini G, et al. Tianeptine treatment induces antidepressive-like effects and alters BDNF and energy metabolism in the brain of rats. Behav Brain Res. 2012;233(2):526-35.
80. Dias BG, Banerjee SB, Duman RS, Vaidya V. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology. 2003;45(4):553-63.
81. Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res. 2008;1211:37-43.
82. aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry. 2010;67(2):139-45.
83. Okamoto N, Nakai T, Skamoto K, Nagafusa Y, Higuchi T, Toru N. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT. 2010;26(3):223-7.
84. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng P, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011;475(7354):91-5.
85. Christian KM, Miracle AD, Wellman CL, Nakazawa K. Chronic stress-induced hippocampal dendritic retraction requires CA3 NMDA receptors. Neuroscience. 2011;174:26-36.
86. Rogóz Z, Skuza G, Legutko B. Repeated cotreatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats. Pharmacol Rep. 2008;60(6): 817-26.
87. Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, et al. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res. 2011;221(1):166-71.